Partial Lower Axillary Dissection for Patients with Clinically Node-negative Breast Cancer

By Kodama H   Mise K   Kan N  

The Journal of International Medical Research, Vol. 40, Iss. 6, 2012-11 ,pp. : 2336-2345

Field House Publishing

Access to resources Recommend Favorite

A deletion in chromosome 11q may predict the response to anthracycline-based chemotherapy in patients with early node-negative breast cancer

By  

Inpharma, Vol. 1, Iss. 1578, 2007-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Is the 21-gene recurrence score a cost-effective assay in endocrine-sensitive node-negative breast cancer?

By Lamond Nathan WD   Skedgel Chris   Younis Tallal  

Expert Review of Pharmacoeconomics and Outcomes Research, Vol. 13, Iss. 2, 2013-04 ,pp. : 243-250

Informa Healthcare

Access to resources Recommend Favorite

Oral uracil-tegafur: an alternative to intravenous 5-fluorouracil?

By Twelves Chris   Jones Rob  

Expert Opinion on Pharmacotherapy, Vol. 2, Iss. 9, 2001-09 ,pp. : 1495-1505

Informa Healthcare

Access to resources Recommend Favorite

Prognostic Significance of Thrombocytosis in Node-negative Colon Cancer

By Kandemir EG   Mayadagli A   Karagoz B   Bilgi O   Turken O   Yaylaci M  

The Journal of International Medical Research, Vol. 33, Iss. 2, 2005-03 ,pp. : 228-235

Field House Publishing

Access to resources Recommend Favorite